| Detected | Trial | Change |
|---|---|---|
| 2026-08-02 | NCT06515964 China Early Esophageal Cancer Cohort |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06512792 Mobile App-Based Remote Management Model for IBD Patient |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06512441 Vitamin B6 Aids in Treating Inflammatory Bowel Disease |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06364397 Efficacy of ERCP in the Diagnosis and Treatment of Idiopathic Recurrent Acute Pancreatitis |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT04536220 Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer |
overall status: Recruiting → Unknown |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-13 | NCT07762950 Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancreatitis | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06937294 | Metformin in Post Chronic Pancreatitis Diabetes Mellitus | Chronic Pancreatitis | Recruiting |
| NCT07088757 | Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis | Post-ERCP Pancreatitis | Recruiting |
| NCT05814848 | A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or… | Relapsed or Refractory B-cell Lymphoma | Not Yet Recruiting |
| Phase 3 | |||
| NCT06427447 | Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) | Pancreatic Cancer | Recruiting |
| Phase 2/3 | |||
| NCT07047339 | Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis | Colitis | Recruiting |
| NCT07134218 | Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in… | Rectal Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT06427460 | Central-boost Ablative Radiation Therapy for Solid Tumors (CBART) | Pancreatic Cancer | Recruiting |
| NCT06394674 | High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With… | Non-Small Cell Lung Cancer | Recruiting |
| NCT07492693 | Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in… | Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors | Recruiting |
| NCT07307456 | Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery… | Bladder Cancer | Recruiting |
| NCT06014944 | Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody | Rectal Cancer | Not Yet Recruiting |
| NCT06210360 | Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX | Pancreatic Cancer | Not Yet Recruiting |
| NCT06927128 | Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma | UTUC | Not Yet Recruiting |
| NCT07490002 | Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in… | Esophageal Squamous Carcinoma | Not Yet Recruiting |
| NCT07492225 | Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial | Neoadjuvant Therapy | Active, Not Recruiting |
| NCT07691593 | Neoadjuvant HRS-4642 Plus Chemotherapy With or Without Immunotherapy for Pancreatic Cancer | Pancreatic Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06492798 | Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients | Long COVID | Recruiting |
| NCT04146298 | Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer | Pancreatic Cancer | Recruiting |
| Phase 1 | |||
| NCT05240950 | Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases | Colorectal Cancer | Recruiting |
| NCT06816823 | CAR-NK Cells (CL-NK-001) in Pancreatic Cancer | Pancreatic Cancer | Recruiting |
| NCT06885710 | HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic… | Chronic Hepatitis b | Recruiting |
| NCT06464679 | An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of… | Autoimmune Diseases | Recruiting |
| NCT07425483 | CAR-NK Cells (CL-NK-003) in Pancreatic Cancer | Pancreatic Cancer | Recruiting |
| NCT07583160 | YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer | Metastatic Castration-Resistant Prostate Cancer Patients | Enrolling by Invitation |
| Early Phase 1 | |||
| NCT06010472 | An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic… | Systemic Lupus Erythematosus (SLE) | Recruiting |